Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

MEDG

Medgenics(Regs) (MEDG)

Medgenics(Regs)
Date:
Sort by:
 Showing the most relevant articles for your search:LSE:MEDG
DateTimeSourceHeadlineSymbolCompany
07/23/20128:30AMUK RegulatoryMedgenics Inc Registration of SharesLSE:MEDGMedgenics(Regs)
07/19/201211:00AMUK RegulatoryMedgenics Inc Admission of Shares to AIMLSE:MEDGMedgenics(Regs)
07/17/201210:43AMUK RegulatoryMedgenics Inc Launch of Phase IIa clinical trial of EPODURETLSE:MEDGMedgenics(Regs)
07/17/20129:50AMUK RegulatoryMedgenics Inc Block Listing interim reviewLSE:MEDGMedgenics(Regs)
07/09/20122:00AMUK RegulatoryMedgenics Inc Admission of SharesLSE:MEDGMedgenics(Regs)
07/02/20129:15AMUK RegulatoryMedgenics Inc Further re. Board AppointmentLSE:MEDGMedgenics(Regs)
07/02/20129:15AMUK RegulatoryMedgenics Inc Medgenics Appoints Dr. Sol Barer as ChairmanLSE:MEDGMedgenics(Regs)
06/28/20129:35AMUK RegulatoryMedgenics Inc Exercise of OptionsLSE:MEDGMedgenics(Regs)
06/20/201211:00AMUK RegulatoryReceives Orphan Drug Designation from FDALSE:MEDGMedgenics(Regs)
06/19/20129:25AMUK RegulatoryMedgenics, Inc. Raises $9.5 millionLSE:MEDGMedgenics(Regs)
06/07/201210:30AMUK RegulatoryMedgenics Initiates U.S. Biopump Processing SiteLSE:MEDGMedgenics(Regs)
05/29/20122:02AMUK RegulatoryChange of NOMADLSE:MEDGMedgenics(Regs)
05/18/201210:00AMRNS Non-RegulatoryMedgenics to Present at 11th Annual ILSI BIOMEDLSE:MEDGMedgenics(Regs)
05/17/201210:00AMUK RegulatoryFDA Clearance for Phase IIb Trial of EPODURELSE:MEDGMedgenics(Regs)
05/14/20121:09PMUK Regulatory1st Quarter ResultsLSE:MEDGMedgenics(Regs)
05/09/201210:00AMUK RegulatoryMedgenics Awarded $2.2 Million GrantLSE:MEDGMedgenics(Regs)
04/27/20122:00AMUK RegulatoryMedgenics Comments on Market Trading ActivityLSE:MEDGMedgenics(Regs)
04/23/201210:00AMUK RegulatoryMedgenics files for U.S. Orphan Drug DesignationLSE:MEDGMedgenics(Regs)
04/17/201210:15AMUK RegulatoryIND Application for Phase IIb EPODURE Anemia StudyLSE:MEDGMedgenics(Regs)
04/05/201211:15AMUK RegulatoryAGM StatementLSE:MEDGMedgenics(Regs)
03/26/201210:00AMUK RegulatoryPositive meeting with NIH RACLSE:MEDGMedgenics(Regs)
03/23/201210:00AMUK RegulatoryClearance to initiate Phase IIA Anemia StudyLSE:MEDGMedgenics(Regs)
03/21/201210:00AMUK RegulatoryPresenting at the Maxim Group Growth ConferenceLSE:MEDGMedgenics(Regs)
03/13/20123:01AMUK RegulatoryParticipation in Roth Conference and Other MattersLSE:MEDGMedgenics(Regs)
03/06/201210:00AMUK RegulatoryFinal ResultsLSE:MEDGMedgenics(Regs)
02/15/201210:00AMRNS Non-RegulatoryMedgenics To Present At LHA Virtual ConferenceLSE:MEDGMedgenics(Regs)
01/25/20121:00PMUK RegulatoryAnnouncement of AGMLSE:MEDGMedgenics(Regs)
01/24/201210:00AMUK RegulatoryTwo Additions to Strategic Advisory BoardLSE:MEDGMedgenics(Regs)
01/20/201210:00AMUK RegulatoryAllowance Received for Key European PatentLSE:MEDGMedgenics(Regs)
01/06/201210:00AMUK RegulatoryIssue of Options and Restricted SharesLSE:MEDGMedgenics(Regs)
 Showing the most relevant articles for your search:LSE:MEDG